Financhill
Back

CRISPR Therapeutics AG 10K Form

Buy
59

CRSP
CRISPR Therapeutics AG

Last Price:
56.80
Seasonality Move:
9.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive CRSP News And Ratings

See the #1 stock for the next 7 days that we like better than CRSP

CRSP Financial Statistics

Sales & Book Value

Annual Sales: $370M
Cash Flow: $109.03M
Price / Cash Flow: 0
Annual Sales: $24.56
Price / Book: 2.23

Profitability

EPS (TTM): -2.69000
Net Income (TTM): $-217.14M
Gross Margin: $239.75M
Return on Equity: 0%
Return on Assets: 0%

CRISPR Therapeutics AG Earnings Forecast

Key CRISPR Therapeutics AG Financial Ratios

  • The Gross Profit Margin over the past 3 years for CRSP is 64.80%.
  • The Selling, General & Administrative Expenses for CRSP have been equal to 20.58% of Gross Profit Margin.
  • The Research & Development expenses have been 104.68% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CRSP is -41.52% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

CRISPR Therapeutics AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRSP
CUSIP: H17182
Website: crisprtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRSP Technical Analysis vs Fundamental Analysis

Buy
59
CRISPR Therapeutics AG (CRSP) is a Buy

Is CRISPR Therapeutics AG a Buy or a Sell?